Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity

NCT07574723 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Tirzepatide (Per-label titration)
DRUG: Tirzepatide (Flexible titration)

Sponsor

Dasman Diabetes Institute

Collaborators

[object Object]